Osinbajo Commissions Jubilee Syringe Factory, 100% Owned By Turkish Investor, Onur Kumral

by Samuel Abasi Posted on September 25th, 2017

Uyo, Nigeria. Sept 24th. Nigeria Vice President Yemi Osinbajo, on Saturday, commissioned a 100% privately owned, 400 million capacity a year syringe manufacturing company in Onna local government area of Akwa Ibom state. Jubilee Syringe Manufacturing (JSM) company is located on an 40000 square meter of land is owned by Turkish investor, Onur Kumral. The commissioning was billed as part  of activities to mark the 30th anniversary of the creation of Akwa Ibom state by the state government.

Osinbajo, who was accompanied at commissioning  by Akwa Ibom state Governor Emmanuel, other governors, and the Minister of Budget and National Planning, Udoma Udo Udoma.

Prior to its commissioning, the largest syringe manufacturing company in Africa was based in South Africa, and had a production capacity of 95 million syringes per year. The Akwa Ibom factory is more than four times that of South Africa.

VP Osinbajo was so impressed with the investment that he described Gov. Emmanuel as “one of the cleverest people I have come across”, ostensibly for the governor’s role in attracting the private investment to the state. Osinbajo said the factory is a “game changer for the nation” as it will lead to the local production of all syringes in the country.

The project is a fully private investment. Turkish owner, Onur Kumral has however credited the Akwa Ibom government for creating an enabling business environment for the company to set up.

Onur Kumral earlier said:

“this factory is 100% private investment. The only support we got from Akwa Ibom State government is in the area of good government and economic policies, land used for the factory and of course, the security of our investment. Our confidence is in Governor Udom Emmanuel and we are very attracted to his vision. People keep telling me the factory would make more sense in Lagos, but I say no, Akwa Ibom needs the factory more.”

An elated Gov. Emmanuel said the factory production capacity would be upgraded to one billion by 2018 by the owner, Jubilee Syringe Manufacturing (JSM) company. He said he was worried about the 100 percent dependence on importation of all medical consumables into the country, hence his decision to encourage the investment by the private investors.

At the commissioning, Onur Kumral said:

“JSM syringes are made from the highest quality, medical grade raw materials with state of the art machinery. JSM seeks to provide Nigerians with the highest quality disposable syringes, thereby helping people of Africa live healthy lives.”

It was also a memorable day for the people of Etinan local government area as the Vice President Yemi Osinbajo stepped in to flung open the doors of the newly reconstructed and equipped General Hospital which had been in dilapidated state for several decades.

Governor Emmanuel who led the Vice President to the hospital in Etinan, said his administration decided to intervene in the hospitals rehabilitation and re-equipping in the ten federal constituencies of the state for even spread of secondary health amenities.

He said all the equipment at the hospital came from the United States of America as his administration’s premium on the health and well-being of the people would not let him compromise on quality.

Vice President Osinbajo expressed hope that the ongoing reconstruction of facilities at other General Hospitals in the state, will also be completed as promised, to the benefit of the people.

The Vice President had earlier commissioned the 400 million capacity Syringe Factory and the Meter Manufacturing Company both in Onna as part of activities to mark the 30th anniversary of the state’s creation.


Photo: Vice President Yemi Osinbajo Commissions Jubilee Syringe Factory, 100% Owned By Turkish Investor, Onur Kumral

Jubilee Syringe Manufacturing (JSM) company with this investment in Nigeria is taking a jab at the global and African syringe export market, as the N15billion ($35million). The estimated 400 million syringes production per annum which Jubilee is starting up with in Nigeria, far overshoots that of a company in South African Company which has a production capacity of 93 million, thereby making Jubilee Syringe the largest syringe manufacturing company on the entire African continent.

The global disposable syringe market is expected to reach $7.5billion (N2.6trillion) in 2022 according to Transparency Market Research. Disposable syringes are the most consumed medical devices in the world. An estimated 39 billion units were sold in 2013, with market value of approximately $4.93billion. The disposable syringes market has been segmented into two major types: safety syringes and conventional syringes.

With projected annual earnings of about $15million (N5.5billion), Jubilee Syringe Manufacturing Company hopes to initially take 500 Nigerian youths off the congested labour market, with further commitment to grow the numbers. The company’s position is to increase the ratio of its Nigerian labour force to 80percent, while 20percent goes to expatriates. The company had sent 12 Nigerians to Istanbul, Turkey, for advance training on key areas of injection machines. These 12 Nigerians were trained in the operation of Injection Moulding Machines, Maintenance of Moulds and Quality Control.

Zubeyir Gulabi, managing director, Jubilee Syringe Manufacturing Company, while conducting investment journalists round the factory, ahead of its commissioning, said the multimillion dollar investment was boosted by Akwa Ibom State Government’s commitment to improved security for people and businesses, simplified land allocation processes, and the Turkish investors’ readiness to leverage Nigeria’s growing market.

Jubilee Syringe Manufacturing factory is a 100 percent private investment. Gulabi said the investors’ stake and speedy execution of the project, define their readiness to encourage other foreigners who are still weighing entry into the Nigeria market.

Author

Samuel Abasi

Samuel Abasi

Staff Writer
Phone
Email

Leave a Reply